Description
MOTS-C UK 10mg Research Peptide
MOTS-C UK 10mg is supplied by SPX Labs as a research material for legitimate laboratory research, analytical testing and scientific evaluation. Each product carries an identifiable batch reference designed to support traceability between the supplied research material and the analytical documentation associated with that batch.
MOTS-C UK Research Material
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide identified through research into short open reading frames within mitochondrial genetic material.
The peptide sequence reported for MOTS-c is MRWQEMGYIFYPRKLR. MOTS-c has subsequently been investigated in experimental research concerning mitochondrial signalling, cellular metabolism and stress-response pathways.
SPX Labs supplies MOTS-C in lyophilised form exclusively as a laboratory research material. It is not supplied as a medicine, supplement or therapeutic product, and SPX Labs does not provide instructions for human or veterinary administration.
Product Profile & Specifications
Product: MOTS-C
Quantity: 10mg
Format: Lyophilised (freeze-dried) research material
Supplier: SPX Labs
Intended use: Laboratory research, analytical testing and scientific evaluation only
Batch identification: Provided on supplied material
Documentation: Batch-specific information available where applicable
The stated 10mg quantity represents the nominal SPX Labs product presentation. Where analytical testing has been performed on a particular batch, the experimentally reported peptide content should be considered separately from the nominal product presentation.
Analytical Testing & Batch Documentation
SPX Labs prioritises batch traceability and analytical transparency. Analytical information is associated with the relevant identifiable batch wherever applicable rather than being presented as a universal specification covering every MOTS-C product supplied.
SPX batch SPX-MOTSC10-001 is associated with supporting analytical documentation reporting:
Reported peptide content: 9.94mg
Reported peptide purity: 99.384%
SPX batch reference: SPX-MOTSC10-001
The reported peptide content represents approximately 99.4% of the nominal 10mg product presentation.
These reported results relate specifically to the analysed sample associated with that batch. They should not be interpreted as a guarantee that every past or future batch will produce identical analytical results.
Researchers can review available batch information through the SPX Labs COA Library and use the SPX batch-verification system to locate information associated with an identifiable SPX batch reference.
Understanding MOTS-C Analytical Information
Analytical techniques are used within peptide research to investigate characteristics of a sample, including identity, peptide content and chromatographic purity where the relevant methods have been performed.
High-performance liquid chromatography (HPLC) is commonly used within peptide analysis to separate components within a sample and assess chromatographic purity. Other analytical techniques may be used where appropriate to provide additional information about peptide identity and composition.
A reported peptide-purity percentage should always be interpreted specifically in relation to the analytical method, tested sample and corresponding batch.
Importantly, a reported chromatographic purity result does not, by itself, establish sterility, endotoxin status, pharmaceutical approval, clinical efficacy or suitability for human or veterinary use.
SPX Labs therefore presents available analytical results as research-material documentation rather than as evidence of pharmaceutical or therapeutic suitability.
MOTS-C Batch Traceability
Each MOTS-C research material supplied by SPX Labs carries an identifiable SPX batch reference. This reference is designed to connect the supplied material with relevant batch information and available supporting analytical documentation.
Researchers should retain this reference when reviewing analytical documentation, using the SPX batch-verification system or contacting SPX Labs regarding a particular product.
The SPX Labs Quality & Testing section provides further information about batch identification, analytical documentation and the internal research-material release criteria used by SPX Labs.
This batch-focused approach helps distinguish analytical information relating to a specific analysed sample from general information about MOTS-C as a research material.
Scientific Research Context
MOTS-c was reported through research investigating previously unrecognised short open reading frames within mitochondrial DNA. Published research describes MOTS-c as a 16-amino-acid mitochondrial-derived peptide associated with the mitochondrial 12S rRNA region.
Researchers seeking neutral compound and sequence information can consult the MOTS-c compound record maintained by PubChem.
The scientific identification and early experimental investigation of MOTS-c are described in the original 2015 Cell Metabolism research paper.
Subsequent scientific literature has investigated MOTS-c in experimental models involving mitochondrial signalling, cellular metabolism and stress-response mechanisms. SPX Labs does not present findings from these experimental studies as established clinical outcomes.
Researchers should evaluate individual publications according to their methodology, experimental model and limitations and distinguish experimental findings from established human clinical evidence.
Storage & Laboratory Handling
Store the research material in accordance with the storage and handling information supplied with the applicable batch.
Appropriate laboratory procedures should be followed when handling research materials, and unnecessary exposure to adverse environmental conditions should be avoided.
Researchers and laboratories remain responsible for determining appropriate handling, storage and experimental procedures for their particular research environment and intended analytical application.
Frequently Asked Questions
What is MOTS-C?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide identified through research into short open reading frames associated with mitochondrial genetic material. It has subsequently become the subject of experimental research investigating mitochondrial and cellular signalling.
Is batch documentation available for MOTS-C?
Where applicable, SPX Labs associates analytical documentation with an identifiable batch reference. Researchers can use the reference printed on the supplied material to locate corresponding information through the SPX COA and batch-verification system.
Does a purity result apply to every SPX Labs MOTS-C batch?
No. Analytical results relate to the specific sample and batch identified in the supporting documentation. SPX Labs does not represent the result from one tested batch as the analytical result for every future batch.
What does 10mg refer to?
10mg is the nominal product presentation. Where analytical peptide-content testing has been performed, the reported analytical result for that particular batch is displayed separately within the relevant batch documentation.
Is MOTS-C supplied for human use?
No. SPX Labs supplies this material exclusively for legitimate laboratory research, analytical testing and scientific evaluation. It is not supplied for human or veterinary consumption or administration.
Laboratory Research Notice
MOTS-C supplied by SPX Labs is intended strictly for legitimate in-vitro laboratory research, analytical testing and scientific evaluation.
It is not supplied for human or veterinary consumption or administration and is not intended to diagnose, treat, cure or prevent disease.
SPX Labs — Precision Research. Verified Quality.
spxlabs.co.uk | info@SPXLabs.co.uk
